Refine by MP, party, committee, province, or result type.

Results 1-8 of 8
Sorted by relevance | Sort by date: newest first / oldest first

Industry committee  There have been a number of studies on the Bayh-Dole Act. Overall they're not incredibly conclusive, as mentioned, about the.... A lot of things happened at the same time, so there aren't a lot of studies that would conclusively point to the Bayh-Dole Act in itself as being the f

May 16th, 2017Committee meeting

Alison McDermott

Industry committee  One of the things we're doing is that we have just been been surveying. In 2016 we undertook a survey of universities and colleges with respect to issues around IP, technology transfer, the work of the technology transfer offices. We're just compiling that data, and disclosure is

May 16th, 2017Committee meeting

Alison McDermott

Industry committee  We are quite interested in studying the level of interaction that's taking place. For example, working with some of our stakeholder groups, Polytechnics Canada and CICan, we can probably get you some information about the levels of activity and partnerships that take place. It's

May 16th, 2017Committee meeting

Alison McDermott

Industry committee  I could come back to you with more information on the strength. I'm not aware of their being terribly weak on the basis of participation rates, but I could find out—

May 16th, 2017Committee meeting

Alison McDermott

May 16th, 2017Committee meeting

Alison McDermott

Industry committee  Great. Thank you, Mark. As mentioned, I'm the director general within ISED's science and innovation sector. We work closely with the granting councils and the post-secondary education sector. Mark has started off with a good overview of the overarching context for IP. In my rem

May 16th, 2017Committee meeting

Alison McDermott

Finance committee  This is a not-for-profit corporation that invests in large-scale genomics projects in areas such as human health, fisheries, forestry, agriculture, environment, and energy. A large portion of the projects to date have been in human health, but there is certainly diversity within

May 9th, 2013Committee meeting

Alison McDermott

Finance committee  I'm Alison McDermott. I'm the acting director general of the program coordination branch at Industry Canada. We're responsible for overseeing the funding agreement with Genome Canada.

May 9th, 2013Committee meeting

Alison McDermott